Page last updated: 2024-11-07

4-fluorothreonine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-fluorothreonine: from Streptomyces cattleya [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Cattleyagenus[no description available]OrchidaceaeA plant family of the order Asparagales. All members of the orchid family have the same bilaterally symmetrical flower structure, with three sepals, but the flowers vary greatly in color and shape.[MeSH]

Cross-References

ID SourceID
PubMed CID128057
CHEBI ID11986
SCHEMBL ID4862149
MeSH IDM0138989

Synonyms (22)

Synonym
BB 0261790
4-fluoro-l-threonine
CHEBI:11986
(2s,3s)-2-amino-4-fluoro-3-hydroxybutanoic acid
4-fluorothreonine
102130-93-8
brn 4372061
threonine, 4-fluoro-
rel-(2s,3s)-2-amino-4-fluoro-3-hydroxybutanoic acid
A1793
AKOS006279840
89426-34-6
AKOS015854039
l-threonine, 4-fluoro-
SCHEMBL4862149
GTFWIYJIEXNAOL-GBXIJSLDSA-N
(2s,3s)-4-fluorothreonine
DTXSID80144678
Q18349175
4-fluoro-threonine
|a-fluoro-l-threonine
rel-(2s,3s)-2-amino-4-fluoro-3-hydroxybutanoicacid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (4)

ClassDescription
amino acid zwitterionThe zwitterionic form of an amino acid having a negatively charged carboxyl group and a positively charged amino group.
fluoroamino acidAn organofluorine compound that consists of an amino acid substituted by a fluoro group.
non-proteinogenic L-alpha-amino acidAny L-alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
L-threonine derivativeA proteinogenic amino acid derivative resulting from reaction of L-threonine at the amino group or the carboxy group, or from the replacement of any hydrogen of L-threonine by a heteroatom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.69)18.7374
1990's2 (15.38)18.2507
2000's4 (30.77)29.6817
2010's4 (30.77)24.3611
2020's2 (15.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.25 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.89 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]